Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD15 is a risk predictor and a novel target in clear cell renal cell carcinoma.
Stenzel PJ, Schindeldecker M, Seidmann L, Herpel E, Hohenfellner M, Hatiboglu G, Foersch S, Porubsky S, Macher-Goeppinger S, Roth W, Tagscherer KE. Stenzel PJ, et al. Among authors: seidmann l. Pathobiology. 2023 Nov 14. doi: 10.1159/000535201. Online ahead of print. Pathobiology. 2023. PMID: 37963432
GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype.
Paret C, Ustjanzew A, Ersali S, Seidmann L, Jennemann R, Ziegler N, Malki KE, Russo A, Wingerter A, Ortmüller F, Bornas A, Wehling PC, Lepădatu A, Ottenhausen M, Roth W, Sommer C, Fliss B, Frauenknecht KBM, Sandhoff R, Faber J. Paret C, et al. Among authors: seidmann l. Cancers (Basel). 2022 Dec 8;14(24):6051. doi: 10.3390/cancers14246051. Cancers (Basel). 2022. PMID: 36551537 Free PMC article.
Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1.
Paret C, Lehmann N, Bender H, Sprang M, Sommer CJ, Cana D, Seidmann L, Wingerter A, Neu MA, El Malki K, Alt F, Roth L, Marini F, Ottenhausen M, Glaser M, Knuf M, Russo A, Faber J. Paret C, et al. Among authors: seidmann l. Cancers (Basel). 2021 Nov 21;13(22):5838. doi: 10.3390/cancers13225838. Cancers (Basel). 2021. PMID: 34830991 Free PMC article.
Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma.
Wingerter A, El Malki K, Sandhoff R, Seidmann L, Wagner DC, Lehmann N, Vewinger N, Frauenknecht KBM, Sommer CJ, Traub F, Kindler T, Russo A, Otto H, Lollert A, Staatz G, Roth L, Paret C, Faber J. Wingerter A, et al. Among authors: seidmann l. Cancers (Basel). 2021 Jan 29;13(3):520. doi: 10.3390/cancers13030520. Cancers (Basel). 2021. PMID: 33572900 Free PMC article.
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma.
Beck O, Paret C, Russo A, Burhenne J, Fresnais M, Steimel K, Seidmann L, Wagner DC, Vewinger N, Lehmann N, Sprang M, Backes N, Roth L, Neu MA, Wingerter A, Henninger N, Malki KE, Otto H, Alt F, Desuki A, Kindler T, Faber J. Beck O, et al. Among authors: seidmann l. Cancers (Basel). 2020 Mar 26;12(4):793. doi: 10.3390/cancers12040793. Cancers (Basel). 2020. PMID: 32224911 Free PMC article.
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor.
Russo A, Paret C, Alt F, Burhenne J, Fresnais M, Wagner W, Glaser M, Bender H, Huprich S, Harter PN, Filipski K, Lehmann N, Backes N, Roth L, Seidmann L, Sommer C, Brockmann MA, Pietsch T, Neu MA, Wingerter A, Faber J. Russo A, et al. Among authors: seidmann l. Int J Mol Sci. 2019 Aug 30;20(17):4267. doi: 10.3390/ijms20174267. Int J Mol Sci. 2019. PMID: 31480400 Free PMC article.
30 results